Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 15/20 | 0.51 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.39 |
| ▸ | CD38 | P28907 | 2/20 | 0.37 |
| ▸ | CLK1 | P49759 | 1/20 | 0.37 |
| ▸ | CLK2 | P49760 | 1/20 | 0.37 |
| ▸ | CLK3 | P49761 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.37 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.37 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29133774 | 0.85 | IRAK4 (0.47) | IRAK4PIK3CACD38CLK4EGFR | |
| SCHEMBL29133704 | 0.83 | IRAK4 (0.54) | IRAK4PIK3CAPIK3CDPIK3CBPIK3CG | |
| SCHEMBL29133701 | 0.82 | PIK3CA (0.38) | IRAK4PIK3CAPIK3CDPIK3CBMTOR | |
| SCHEMBL29133759 | 0.81 | EGFR (0.57) | PIK3CACD38CLK4EGFR | |
| SCHEMBL29133728 | 0.81 | IRAK4 (0.48) | IRAK4CD38CLK1CLK2CLK3 | |
| SCHEMBL29133711 | 0.80 | PIK3CA (0.41) | IRAK4PIK3CACLK4EGFR | |
| SCHEMBL29133716 | 0.79 | IRAK4 (0.39) | IRAK4CLK1CLK4EGFR | |
| SCHEMBL29133742 | 0.79 | IRAK4 (0.35) | IRAK4PIK3CAPIK3CDCD38CLK1 | |
| SCHEMBL29133745 | 0.77 | HTT (0.50) | IRAK4MTOR | |
| SCHEMBL29133739 | 0.77 | HTT (0.50) | IRAK4MTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117295716-A | Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors | 麦克尼斯迪克治疗有限公司 | 2023-12-26 | — | — | CN | disclosed |